Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2020 Sep 30;408:115258. doi: 10.1016/j.taap.2020.115258

Fig. 7.

Fig. 7.

TCE treatment led to increased NF-κB (p65) expression in MRL+/+ mice, which was alleviated SFN supplementation. Representative Western blot for p-NF-κB (p65) in the spleens of MRL+/+ mice following treatment with TCE or TCE + SFN for 6 weeks. The data are presented as means ± SD (n = 6). * p < 0.05 vs. controls, # p < 0.05 vs. TCE-treated mice.